Maze Therapeutics (MAZE) Form 3: CFO Reports No Holdings — 09/02/2025

Q: What does the Form 3 filed for MAZE say about Tahir Misbah's holdings?

The Form 3 states that Tahir Misbah (CFO and director) owns no securities beneficially according to the filing.

Q: What is Tahir Misbah's role at Maze Therapeutics (MAZE)?

The filing identifies him as the company's Chief Financial Officer and a director.

Q: Was the Form 3 filed jointly or by one reporting person for MAZE?

The filing indicates it was submitted by one reporting person (not a joint or group filing).

Q: Who signed the Form 3 for Tahir Misbah on the MAZE filing?

The signature block shows the form was signed by /s/ Courtney Phillips, as attorney-in-fact.

Q: What date is listed as the event requiring the Form 3 for MAZE?

The form lists the date of the event as 09/02/2025.

Tahir Misbah, identified as Chief Financial Officer and a director of Maze Therapeutics, Inc. (Ticker: MAZE), submitted an initial Form 3 reporting his beneficial ownership status.

Accepted by SEC EDGAR 09/02/2025 - 06:29 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Tahir Misbah, identified as Chief Financial Officer and a director of Maze Therapeutics, Inc. (Ticker: MAZE), submitted an initial Form 3 reporting his beneficial ownership status. The filing states no securities are beneficially owned by the reporting person. The form was executed through an attorney-in-fact signature on the submitted document.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filed for MAZE say about Tahir Misbah's holdings?

The Form 3 states that Tahir Misbah (CFO and director) owns no securities beneficially according to the filing.

What is Tahir Misbah's role at Maze Therapeutics (MAZE)?

The filing identifies him as the company's Chief Financial Officer and a director.

Was the Form 3 filed jointly or by one reporting person for MAZE?

The filing indicates it was submitted by one reporting person (not a joint or group filing).

Who signed the Form 3 for Tahir Misbah on the MAZE filing?

The signature block shows the form was signed by /s/ Courtney Phillips, as attorney-in-fact.

What date is listed as the event requiring the Form 3 for MAZE?

The form lists the date of the event as 09/02/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tahir Misbah

(Last)

(First)

(Middle)

C/O MAZE THERAPEUTICS, INC.

171 OYSTER POINT BOULEVARD, SUITE 300

(Street)

SOUTH SAN FRANCISCO

94080

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/02/2025

3. Issuer Name and Ticker or Trading Symbol
Maze Therapeutics, Inc. [ MAZE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

No securities are beneficially owned.

	/s/ Courtney Phillips, as attorney-in-fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR